Full-Time
Posted on 3/12/2025
Develops and manufactures biopharmaceutical products
$25.33 - $42.22Hourly
Entry, Junior
No H1B Sponsorship
Phoenixville, PA, USA
Relocation assistance may be available based on business needs and/or eligibility.
Pfizer is a biopharmaceutical company that focuses on creating and manufacturing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then commercialized and sold to various clients such as governments, healthcare providers, and patients. Pfizer's products include vaccines, oncology treatments, and specialized medicines, with a notable contribution to the COVID-19 pandemic through its partnership with BioNTech to develop a widely used vaccine. What sets Pfizer apart from its competitors is its strong commitment to public health, exemplified by efforts to provide vaccines to underserved populations and a continuous expansion of its product portfolio through new approvals. The goal of Pfizer is to improve global health by ensuring access to effective treatments and vaccines.
Company Size
10,001+
Company Stage
IPO
Headquarters
New York City, New York
Founded
1849
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
Relocation Assistance
Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding
Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The
The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.
New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is